logo
Flow cytometry in cerebrospinal fluid—Rational use of laboratory services
Safe and successful bone marrow biopsy: An anatomical and CT-based cadaver study
Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia
FOXO3-mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis
Gemtuzumab ozogamicin with fludarabine, cytarabine, and granulocyte colony stimulating factor (FLAG-GO) as front-line regimen in patients with core binding factor acute myelogenous leukemia
Rituximab–cyclophosphamide-dexamethasone is highly effective in patients with monoclonal Ig deposit-related glomerulopathy and indolent non-Hodgkin lymphomas
Genetic deletion of the GATA1-regulated protein α-synuclein reduces oxidative stress and nitric oxide synthase levels in mature erythrocytes
Diagnostic utility of cerebrospinal fluid flow cytometry in patients with and without prior hematologic malignancy
Exploiting pre-rRNA processing in Diamond Blackfan anemia gene discovery and diagnosis
Cranial radiation for pediatric T-lineage acute lymphoblastic leukemia: A systematic review and meta-analysis
Multiple myeloma: 2014 Update on diagnosis, risk-stratification, and management
Peripheral blood features of acute myeloid leukemia with myelodysplasia-related changes developing in a patient with sickle cell anemia
Two cases of concomitant diffuse large B-cell lymphoma and myelodysplastic syndrome
Cutaneous involvement by multiple myeloma
The role of intravenous iron for the treatment of restless legs syndrome
BCR-ABL1 kinase domain mutational analysis of CD34+ stem/progenitor cells in newly diagnosed CML patients by next-generation sequencing
New oral anticoagulants may not be effective to prevent venous thromboembolism in patients with antiphospholipid syndrome
Monosomal karyotype is an independent predictor of survival in patients with higher-risk myelodysplastic syndrome
Retrospective cohort study of 205 cases with congenital dyserythropoietic anemia type II: Definition of clinical and molecular spectrum and identification of new diagnostic scores
Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients
First-line treatment of 102 chronic myeloid leukemia patients with imatinib: A long-term single institution analysis
Silent cerebral infarction, income, and grade retention among students with sickle cell anemia